Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal

Clinical Orthopaedics and Related Research

Volumn 349, Issue , 1998, Pages 194-199

  Yonemoto, Tsukasa ^a   Tatezaki, Shin Ichiro ^a   Ishii, Takeshi ^a   Satoh, Tetsuzo ^a   Kimura, Hideki ^a   Iwai, Naomichi ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BONE CANCER; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG CANCER; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY;

EID: 0031956977     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199804000-00024     Document Type: Article

References (15)

1. Belli L, Scholl S, Livartowski A, et al: Resection of pulmonary metastases in osteosarcoma: A retrospective analysis of 44 patients. Cancer 63:2546-2550, 1989.
2. Ettinger LJ, Douglass Jr HO, Higby DJ, et al: Adjuvant Adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer 47:248-254, 1981.
3. Goorin AM, Delorey MJ, Lack EE, et al: Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: Analysis of 32 patients. J Clin Oncol 2:425-431, 1984.
4. Levine AS, Appelbaum FR, Graw Jr RG, et al: Sequential combination chemotherapy (containing high dose cyclophosphamide) for metastatic osteogenic sarcoma. Cancer Treat Rep 62:247-250, 1978.
5. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1606, 1986.
6. Marina NM, Pratt CB, Rao BN, Shema SJ: Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 75:2722-2727, 1992.
7. Meyer WH, Schell MJ, Kumar M, et al: Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indication of survival. Cancer 59:374-379, 1987.
8. Meyers PA, Heller G, Healey JH, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
9. Meyers PA, Heller G, Healey JH, et al: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449-453, 1993.
10. Nachman J, Simon MA, Dean L, et al: Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol 5:1185-1190, 1987.
11. Perez C, Herson J, Kimball JC, Sutow WW: Prognosis after metastases in osteosarcoma. Cancer Clin Trials 1:315-320, 1978.
12. Pratt CB, Rivera G, Shanks E, et al: Combination chemotherapy for osteosarcoma. Cancer Treat Rep 62:251-257, 1978.
13. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163-2177, 1979.
14. Sutow WW, Herson J, Perez C: Survival after metastases in osteosarcoma. Monogr Natl Cancer Inst 56:227-231, 1981.
15. Tatezaki S, Satoh T, Saitoh S, et al: Treatment for pulmonary metastatic osteosarcoma. Kotsu Kansetsu Jintai 7:357-362, 1994. In Japanese.